乳腺癌骨转移意外摄取[68Ga]Ga-DOTATATE的病例解读
本文报告一例66岁女性小叶乳腺癌患者,同时偶然发现肺典型类癌;在[68Ga]Ga-DOTATATE PET/CT分期类癌时,发现两处SSTR2阳性骨病灶,无[18F]FDG摄取但伴轻度硬化,活检证实为乳腺癌骨转移。病例提示在多示踪剂方法中需警惕非典型表现,整合受体表达与形态学特征。
要点
- 小叶乳腺癌[18F]FDG摄取常偏低,可能限制转移灶检出敏感性。
- SSTR2在部分乳腺癌尤其雌激素受体丰富肿瘤中显著表达。
- 骨病灶SSTR2阳性且无FDG摄取时,需活检鉴别乳腺癌转移与类癌转移。
核心结论
- 乳腺癌骨转移可表现为SSTR2阳性而[18F]FDG阴性的非典型影像,需结合活检确认。
研究设计与样本
- 单例病例报告:66岁女性小叶乳腺癌患者,偶然发现肺典型类癌,行[68Ga]Ga-DOTATATE PET/CT分期。
主要发现
- [68Ga]Ga-DOTATATE PET/CT显示两处SSTR2阳性骨病灶,无[18F]FDG摄取,伴轻度硬化,不典型于类癌转移。
- 骨活检证实为乳腺癌骨转移。
关键数值与推荐
- 约63%的高分化肺类癌表达SSTR2;小叶乳腺癌[18F]FDG摄取常偏低。
临床怎么用
- 多示踪剂PET/CT评估时,应整合受体表达与形态学,对不典型骨病灶考虑活检以明确来源。
局限性
- 单例病例报告,结论外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Lobular breast cancer often shows only low [18F]FDG uptake, limiting the sensitivity to detect metastases. Alternative tracers, targeting tumor activated fibroblasts or estrogen receptors, can offer higher accuracy. Also, Somatostatin Receptor 2 (SSTR2) is significantly expressed in some breast cancers, particularly in estrogen receptor rich tumors. Typical pulmonary carcinoids also have low [18F]FDG accumulation, but approximately 63% of well-differentiated lesions express SSTR2. CASE PRESENTATION: We report the case of a 66-year-old female patient with lobular breast cancer and a coincidentally discovered typical carcinoid of the lung. On subsequent [68Ga]Ga-DOTATATE PET/CT to stage the carcinoid tumor, two SSTR2 positive focal lesions in the bones were present, without [18F]FDG uptake but with mild sclerosis, atypical for metastasis of carcinoids. Biopsy confirmed osseous breast cancer metastases. CONCLUSION: SSTR2 expression in normal breast tissue and breast carcinoma has been described previously. However, the case underscores the importance of awareness of atypical presentations of cancer within a multi-tracer approach, whereby receptor profile and morphology must be carefully integrated.
引用
- Kemle J, Pop SG, Sauter A, et al. Incidental [68Ga]Ga-DOTATATE uptake in bone metastases of breast carcinoma in a patient with a secondary carcinoid tumor. EJNMMI Res. 2026. PMID: 42274953. doi:10.1186/s13550-026-01462-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。